Risk of Myocarditis After Sequential Doses of COVID-19 Vaccine and SARS-CoV-2 Infection by Age and Sex.

Martina Patone Winnie Xue Mei Lahiru HandunnetthiSharon DixonFrancesco Zaccardi Manu Shankar-HariPeter WatkinsonKamlesh KhuntiAnthony HarndenCarol A C CouplandKeith M ChannonNicholas L Mills Aziz Sheikh Julia Hippisley-Cox

Published in: Circulation (2022)

Overall, the risk of myocarditis is greater after SARS-CoV-2 infection than after COVID-19 vaccination and remains modest after sequential doses including a booster dose of BNT162b2 mRNA vaccine. However, the risk of myocarditis after vaccination is higher in younger men, particularly after a second dose of the mRNA-1273 vaccine.

Keyphrases

coronavirus disease
sars cov
respiratory syndrome coronavirus
binding protein
middle aged